Ranitidine

Manufacturer: Dr. Reddy's Laboratories Limited
Effective date: 2025-05-23
Label type: HUMAN OTC DRUG LABEL
Version: 11
Source: full-release
Hydrated at: 2026-06-01 01:01:35

Label at a glance#

ProductRanitidine

Active ingredientranitidine hydrochloride

Label structure11 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) do not chew tablet children under 12 years: ask a doctor

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-888-375-3784

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.
These may be signs of a serious condition. See your doctor.
with other acid reducers

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain
kidney disease

Ask a doctor or pharmacist before use if you are

SPL UNCLASSIFIED SECTION

• taking a prescription drug. Acid reducers may interact with certain prescription drugs.

Stop use and ask a doctor if

OTC - STOP USE SECTION

your heartburn continues or worsens
you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over:
- to relieve symptoms, swallow 1 tablet with a glass of water
- to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
- can be used up to twice daily (do not take more than 2 tablets in 24 hours)
- do not chew tablet
children under 12 years: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

this product is sodium and sugar free
Blister: do not use if individual blister unit is open or torn
Bottle: do not use if printed foil under bottle cap is open or torn
avoid excessive heat or humidity
store at 20°-25°C (68°-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.

OTC - QUESTIONS SECTION

Questions? call 1-888-375-3784

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ranitidine Tablets USP, 75 mg - container label

container

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Ranitidine Tablets USP, 75 mg - Container CartonLabel

containercarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
312773	ranitidine 75 MG Oral Tablet	PSN	11
312773	ranitidine 75 MG Oral Tablet	SCD	11
312773	ranitidine 75 MG (as ranitidine hydrochloride 84 MG) Oral Tablet	SY	11

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
RANITIDINE Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7f54af34-be54-4c3c-894f-78df6452d747	Product name	3	20190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850	Product name	5	20190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7b	Product name	1	20180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228	Product name	1	20160720

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55111-131-04	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-14	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-30	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-37	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-45	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-60	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-79	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-80	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-81	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-90	2025-05-27	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-04	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-14	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-30	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-37	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-45	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-60	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-79	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-80	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-81	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts
55111-131-90	2025-01-30	C162847	48780-1	2cef2736-a539-d83d-e063-dadaa90ab31f	Drug Facts

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55111-131	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	11	Current NDC, Legacy NDC	20250529_12a38e29-130c-6d41-1753-acccb0b41efe.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-131-60	EA - Each	55111-131	0f78e0cf-e93c-462a-ac98-19f5df909814	1	2018-12-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	6
ranitidine	ACTIVE MOIETY	884KT10YB7	6
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	6
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	6
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	6
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	6
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	6
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

Ranitidine
ranitidine hydrochloride
HYPROMELLOSES
magnesium stearate
cellulose, microcrystalline
Polyethylene Glycol, Unspecified
ferrosoferric oxide
titanium dioxide

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55111-131	55111-131-30, 55111-131-60, 55111-131-80, 55111-131-90, 55111-131-04, 55111-131-37, 55111-131-79, 55111-131-14, 55111-131-81, 55111-131-45

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ranitidine hydrochloride	BK76465IHM	ACTIM
HYPROMELLOSES	3NXW29V3WO	IACT
magnesium stearate	70097M6I30	IACT
cellulose, microcrystalline	OP1R32D61U	IACT
Polyethylene Glycol, Unspecified	3WJQ0SDW1A	IACT
ferrosoferric oxide	XM0M87F357	IACT
titanium dioxide	15FIX9V2JP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 55 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Maximum daily exposure	Match
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET / ORAL	6184 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / ORAL	980 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET / ORAL	1127 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET / ORAL	232 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates
ferrosoferric oxide	FERROSOFERRIC OXIDE	XM0M87F357	TABLET / ORAL	2 mg	Exact identifier — unii+route+dosage form 11 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075294-001	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL			2000-03-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ranitidine	RANITIDINE	Dr. Reddy's Laboratories Limited	12a38e29-130c-6d41-1753-acccb0b41efe	2025-05-23	Warnings	Exact identifier ndc (package): 55111-131-90 ndc (package): 55111-131-80 ndc (package): 55111-131-30 ndc (package): 55111-131-37 ndc (package): 55111-131-14 ndc (package): 55111-131-04 ndc (package): 55111-131-60 ndc (package): 55111-131-81 ndc (package): 55111-131-79 ndc (package): 55111-131-45 ndc (product): 55111-131 ndc11 (package): 55111013104 ndc11 (package): 55111013190 ndc11 (package): 55111013130 ndc11 (package): 55111013180 ndc11 (package): 55111013160 ndc11 (package): 55111013137 ndc11 (package): 55111013145 ndc11 (package): 55111013114 ndc11 (package): 55111013179 ndc11 (package): 55111013181 spl id: 210e3c0b-be93-aa50-550d-e383e7d5f19e spl set id: 12a38e29-130c-6d41-1753-acccb0b41efe

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.